drugset / Trial / NCT02009709
Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to determine the effectiveness and safety of corneal collagen cross-linking at irradiance levels of 9 and 18 mW/cm2.
Timeline
- Start
- 2013-10
- Primary completion
- 2017-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Riboflavin | Other / unclassified | 0.1 % | Other |